Secondary Acute Myeloid Leukemia (sAML): Similarly Dismal Outcomes of AML After an Antecedent Hematologic Disorder and Therapy Related AML
- 1 October 2021
- journal article
- research article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 22 (4), e233-e240
- https://doi.org/10.1016/j.clml.2021.09.019
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of MyelodysplasiaClinical Lymphoma Myeloma and Leukemia, 2016
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort StudyJournal of Clinical Oncology, 2015
- Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remissionBone Marrow Transplantation, 2015
- Acute myeloid leukemia ontogeny is defined by distinct somatic mutationsBlood, 2015
- Characteristics and outcome of therapy‐related myeloid neoplasms: Report from the Italian network on secondary leukemiasAmerican Journal of Hematology, 2015
- Characterization and prognostic features of secondary acute myeloid leukemia in a population‐based setting: A report from the Swedish Acute Leukemia RegistryAmerican Journal of Hematology, 2014
- Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid NeoplasmsJournal of Clinical Oncology, 2012
- The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AMLBlood, 2011
- Prognostic factors and treatment outcome in 1,516 adult patients with de novo and secondary acute myeloid leukemia in 1999–2009 in 5 hematology intensive care centers in the Czech RepublicNeoplasma, 2010